SlideShare a Scribd company logo
1 of 4
Guillermo (Bill) Martinez
Objective
My objectives are to employ Lean Six Sigma tools and years of management experience in
the Healthcare setting to meet the needs of customers.
Experience
Dec. 2010 - Present
Creative Testing Solutions, Inc., St. Petersburg, FL.
Technical Director – DTL (full-time hours worked)
 Provide technical and administrative direction to a staff of 50 dedicated technologists
working in a highly automated donor-testing laboratory performing approximately
15,000,000 tests per year for over 40 different clients.
 Collaborate with the Medical Director and the Quality Department to achieve the highest
degree of regulatory compliance (no 483 forms in the last three FDA inspections).
 Developed a training program for Medical Technologists in 2012. The program is licensed
by the State of Florida.
 Trained staff in Operational Excellence and the Shingo Principles.
 Helped improve lab operations by removing excess motion of samples and people.
 Research coordinator of a protocol evaluating the specificity of the cobas Zika test for the
detection of Zika virus in homologous blood donors (protocol No. cX8-ZIKA-412).
 Research coordinator of a protocol evaluating a system for the detection of Dengue virus
RNA in plasma specimens from individual human donors, including volunteer donors of
whole blood and, blood components and other living donors in the US and Puerto Rico
(DENVTS-US12-002).
 Research coordinator of protocols evaluating next generation WNV, HIV, HCV and HBV
PCR assays from Roche Molecular Systems on the cobas 8800 system.
 Research coordinator of protocols evaluating next generation PCR assays from Hologics
using the Procleix Panther® system.
1990-Dec 2010
LifeSouth Community Blood Centers, Inc. Gainesville, FL.
Technical Director (full-time hours worked)
 Provided technical and administrative direction to a staff of 24 team members working in a
highly automated donor-testing laboratory performing approximately 3,000,000 tests per
year.
 Provided technical and administrative direction to highly qualified staff of seven specialists
Page 1 of 4
Achieve Office (727) 578-3226
Cell (352) 275-4235
E-mail Gam0811@yahoo.com
108 44th
AVE NE
St. Pete, FL. 33703
who worked in a reference and quality control laboratory performing highly specialized
immunohematology, hematology, molecular and flowcytometry assays.
 Developed LifeSouth’s training program for Medical Technologists in 2006. The program is
licensed by the State of Florida, license number TP 258.
 Developed LifeSouth’s bilingual translation services for blood donation
 Hired and retained a core group of outstanding managers, supervisors, and technical staff.
 Research coordinator and sub-investigator of a protocol determining the value of banking
cord blood for transplantation (BB-IND 7520).
 Research coordinator and sub-investigator of a protocol evaluating the use of TMA to
detect WNV in volunteer blood donors (2003BBWBWNV- 04)
 Research coordinator of a post-market study titled “Identification of Confirmed HBV Yield
Cases Using the PROCLEIX ULTRIO Assay in Blood Donations”
 Research coordinator and sub-investigator of protocols evaluating the use RT-PCR to
detect HIV (Protocol No: AS-HIV-046), and HCV in volunteer blood donors (Protocol No: AS-
HCV-025)
 Deputy Project Director for HRSA’s contract with LifeCord in support of the National Cord
Blood Inventory HHSH234200867003C
Medical Technologist (full-time hours worked)
 1986–1989 Veterans Administration Medical Center. Gainesville, FL
 General clinical lab duties
Medical Technologist (part-time 20 hours per pay period)
 1987–1988 Shands Teaching Hospital. Gainesville, FL
 Part-time Blood Bank
1983–1986 Alachua General Hospital. Gainesville, FL (full-time
hours worked)
 General clinical lab duties
1978–1982 US Navy
 Hospital Corpsman
Education
1990–1994 University of Central Florida. Orlando, FL
 MS, Health Services Administration
1982–1986 University of Florida. Gainesville FL
 BS, Medical Technology
Page 2 of 2
2016 - Villanova University on line
• Lean Six Sigma certificate.
• Pursuing Six Sigma Black Belt certification with emphasis in health care
Skills
 Speak Spanish fluently.
 Experienced user of MS Office software.
 Knowledgeable of FDA, CMS, and OHRP regulations, as well as good laboratory practices,
CAP and AABB Standards.
 Yellow belt in Six Sigma.
 Lean practitioner certificate from Villanova University
Affiliations
American Society for Quality
American College of Health Care Executives
American Legion
American Society of Clinical Pathologists
American Association of Blood Bank
Publicatio
ns
 Abdel-Mageed A, del Rosario MLU, Hutcheson CE, Iturraspe JA,
Martinez G, Roberts CG, Wingard JR: Effect of temperature variation
and duration from collection to processing of umbilical HPC, cord
blood units on cell number, viability, and clonogenic potential. Blood
90(10, Suppl 1):321b, Abstract #4194, 1997
 Abdel-Mageed A, Hutcheson CE, Braylan RC, Metz SJ, Iturraspe JA,
del Rosario MLU, Pardo PJ, Eckert N, Martinez G, Fisk DD, Sugrue
MW, Roberts CF, Wingard JR: Feasibility of umbilical HPC, cord blood
unit collection and processing for volume reduction and thawing:
Effect on cell loss, viability, and clonogenic potential. Blood 90(10,
Suppl 1):321b, Abstract #4195.Hubl, W. et. Al. Effect of Storage on
Stem Cell Concentration and Viability in Cord Blood. ASH Abstract
Submission.
 Hubl W, Iturraspe J, Martinez GA, Hutcheson CE, Roberts CG, Fisk
DD, Sugrue MW, Wingard JR, Braylan RC. Measurement of absolute
concentration and viability of CD34+ cells in HPC, cord blood and
HPC, cord blood products using fluorescent beads and cyanine
Page 3 of 2
nucleic acid dyes. Cytometry 1998; 34(3):121-127.
 B. Martinez, et. Al. Comparative testing for weak expression of D antigen:
manual tube testing vs. a semi-automated IgG gel system
 G. Martinez, N. Haubert, G. Leparc, P. Williamson, R. Spizman, .
Robertson G, S. Caglioti, J. Dunn-Williams, M. Dixon, Comparison of
Reactive Rates Between EIA and Chemi- luminescent Donor Screening
Assays. CONTROL ID: 2006291, AABB abstract 2013.
 Evaluation of High Triglycerides Concentrations for Interference with
Immucor’s DonorScreen-HLA® Assay. Guillermo Martinez1, Phillip C.
Williamson, German F. Leparc, Jennifer Ritter, Sally Caglioti, Cheryl
Amaral
Page 4 of 2

More Related Content

What's hot

Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...
Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...
Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...Golden Helix
 
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...Golden Helix
 
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP GuidelinesVSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP GuidelinesGolden Helix
 
Using Golden Helix CancerKB to Accelerate NGS Cancer Testing
Using Golden Helix CancerKB to Accelerate NGS Cancer TestingUsing Golden Helix CancerKB to Accelerate NGS Cancer Testing
Using Golden Helix CancerKB to Accelerate NGS Cancer TestingGolden Helix
 
Oncogenicity Scoring in VSClinical
Oncogenicity Scoring in VSClinicalOncogenicity Scoring in VSClinical
Oncogenicity Scoring in VSClinicalGolden Helix
 
Cancer Workflows in VarSeq
Cancer Workflows in VarSeqCancer Workflows in VarSeq
Cancer Workflows in VarSeqGolden Helix
 
Jan2015 using the pilot genome rm for clinical validation steve lincoln
Jan2015 using the pilot genome rm for clinical validation steve lincolnJan2015 using the pilot genome rm for clinical validation steve lincoln
Jan2015 using the pilot genome rm for clinical validation steve lincolnGenomeInABottle
 
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...Golden Helix
 
Bacterial Pathogen Genomics at NCBI
Bacterial Pathogen Genomics at NCBIBacterial Pathogen Genomics at NCBI
Bacterial Pathogen Genomics at NCBInist-spin
 
Genomics, Bioinformatics, and Pathology
Genomics, Bioinformatics, and PathologyGenomics, Bioinformatics, and Pathology
Genomics, Bioinformatics, and PathologyDan Gaston
 
16S MVRSION at Washington University
16S MVRSION at Washington University16S MVRSION at Washington University
16S MVRSION at Washington UniversitySeth Crosby
 
North America Toxicology Laboratories Market Analysis | Coherent Market Insights
North America Toxicology Laboratories Market Analysis | Coherent Market InsightsNorth America Toxicology Laboratories Market Analysis | Coherent Market Insights
North America Toxicology Laboratories Market Analysis | Coherent Market InsightsCoherent Market Insights
 
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference Database
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference DatabaseDevelopment of FDA MicroDB: A Regulatory-Grade Microbial Reference Database
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference DatabaseNathan Olson
 
ACMG-Based Variant Classification with VSClinical
ACMG-Based Variant Classification with VSClinicalACMG-Based Variant Classification with VSClinical
ACMG-Based Variant Classification with VSClinicalGolden Helix
 

What's hot (20)

Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...
Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...
Introducing VSClinical AMP Guidelines: A Comprehensive Workflow for NGS Testi...
 
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...
Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Ca...
 
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP GuidelinesVSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
 
Using Golden Helix CancerKB to Accelerate NGS Cancer Testing
Using Golden Helix CancerKB to Accelerate NGS Cancer TestingUsing Golden Helix CancerKB to Accelerate NGS Cancer Testing
Using Golden Helix CancerKB to Accelerate NGS Cancer Testing
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
 
Compar
ComparCompar
Compar
 
Com par 25jun14
Com par 25jun14Com par 25jun14
Com par 25jun14
 
Oncogenicity Scoring in VSClinical
Oncogenicity Scoring in VSClinicalOncogenicity Scoring in VSClinical
Oncogenicity Scoring in VSClinical
 
Cancer Workflows in VarSeq
Cancer Workflows in VarSeqCancer Workflows in VarSeq
Cancer Workflows in VarSeq
 
Jan2015 using the pilot genome rm for clinical validation steve lincoln
Jan2015 using the pilot genome rm for clinical validation steve lincolnJan2015 using the pilot genome rm for clinical validation steve lincoln
Jan2015 using the pilot genome rm for clinical validation steve lincoln
 
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...
Clinical Validation of Copy Number Variant Detection by Next-Generation Seque...
 
I evobio zilversmit_25jun14
I evobio zilversmit_25jun14I evobio zilversmit_25jun14
I evobio zilversmit_25jun14
 
In sillico 2 send
In sillico 2 sendIn sillico 2 send
In sillico 2 send
 
Bacterial Pathogen Genomics at NCBI
Bacterial Pathogen Genomics at NCBIBacterial Pathogen Genomics at NCBI
Bacterial Pathogen Genomics at NCBI
 
A Walk Through GWAS
A Walk Through GWASA Walk Through GWAS
A Walk Through GWAS
 
Genomics, Bioinformatics, and Pathology
Genomics, Bioinformatics, and PathologyGenomics, Bioinformatics, and Pathology
Genomics, Bioinformatics, and Pathology
 
16S MVRSION at Washington University
16S MVRSION at Washington University16S MVRSION at Washington University
16S MVRSION at Washington University
 
North America Toxicology Laboratories Market Analysis | Coherent Market Insights
North America Toxicology Laboratories Market Analysis | Coherent Market InsightsNorth America Toxicology Laboratories Market Analysis | Coherent Market Insights
North America Toxicology Laboratories Market Analysis | Coherent Market Insights
 
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference Database
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference DatabaseDevelopment of FDA MicroDB: A Regulatory-Grade Microbial Reference Database
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference Database
 
ACMG-Based Variant Classification with VSClinical
ACMG-Based Variant Classification with VSClinicalACMG-Based Variant Classification with VSClinical
ACMG-Based Variant Classification with VSClinical
 

Similar to Resume_Bill_Martinez

Similar to Resume_Bill_Martinez (20)

Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Robert E. Parson Resume
Robert E. Parson ResumeRobert E. Parson Resume
Robert E. Parson Resume
 
Development and Clinical Validation of Liquid ddPCR Tests for Actionable Soma...
Development and Clinical Validation of Liquid ddPCR Tests for Actionable Soma...Development and Clinical Validation of Liquid ddPCR Tests for Actionable Soma...
Development and Clinical Validation of Liquid ddPCR Tests for Actionable Soma...
 
NIH Drug Discovery and Development - NCTT and CTSAs
NIH Drug Discovery and Development - NCTT and CTSAsNIH Drug Discovery and Development - NCTT and CTSAs
NIH Drug Discovery and Development - NCTT and CTSAs
 
Resume Technical
Resume TechnicalResume Technical
Resume Technical
 
Robert Pesich_PAVA_Stanford Resume v. 8_22_16
Robert Pesich_PAVA_Stanford Resume v. 8_22_16Robert Pesich_PAVA_Stanford Resume v. 8_22_16
Robert Pesich_PAVA_Stanford Resume v. 8_22_16
 
David.Carr.Resume 18
David.Carr.Resume 18David.Carr.Resume 18
David.Carr.Resume 18
 
BattagliaL_2016
BattagliaL_2016BattagliaL_2016
BattagliaL_2016
 
V Shyamala Resume
V Shyamala ResumeV Shyamala Resume
V Shyamala Resume
 
jlm resume (Nov.2016)
jlm resume (Nov.2016)jlm resume (Nov.2016)
jlm resume (Nov.2016)
 
P Dawson CV_6-14
P Dawson CV_6-14P Dawson CV_6-14
P Dawson CV_6-14
 
Resume_BB
Resume_BBResume_BB
Resume_BB
 
Hao Liu Resume 2017-02
Hao Liu Resume 2017-02Hao Liu Resume 2017-02
Hao Liu Resume 2017-02
 
Maples PB Resume 010417
Maples PB Resume 010417Maples PB Resume 010417
Maples PB Resume 010417
 
QPS Bioanalysis
QPS BioanalysisQPS Bioanalysis
QPS Bioanalysis
 
Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016
 
Oncology PRA Health Sciences
Oncology PRA Health SciencesOncology PRA Health Sciences
Oncology PRA Health Sciences
 

Resume_Bill_Martinez

  • 1. Guillermo (Bill) Martinez Objective My objectives are to employ Lean Six Sigma tools and years of management experience in the Healthcare setting to meet the needs of customers. Experience Dec. 2010 - Present Creative Testing Solutions, Inc., St. Petersburg, FL. Technical Director – DTL (full-time hours worked)  Provide technical and administrative direction to a staff of 50 dedicated technologists working in a highly automated donor-testing laboratory performing approximately 15,000,000 tests per year for over 40 different clients.  Collaborate with the Medical Director and the Quality Department to achieve the highest degree of regulatory compliance (no 483 forms in the last three FDA inspections).  Developed a training program for Medical Technologists in 2012. The program is licensed by the State of Florida.  Trained staff in Operational Excellence and the Shingo Principles.  Helped improve lab operations by removing excess motion of samples and people.  Research coordinator of a protocol evaluating the specificity of the cobas Zika test for the detection of Zika virus in homologous blood donors (protocol No. cX8-ZIKA-412).  Research coordinator of a protocol evaluating a system for the detection of Dengue virus RNA in plasma specimens from individual human donors, including volunteer donors of whole blood and, blood components and other living donors in the US and Puerto Rico (DENVTS-US12-002).  Research coordinator of protocols evaluating next generation WNV, HIV, HCV and HBV PCR assays from Roche Molecular Systems on the cobas 8800 system.  Research coordinator of protocols evaluating next generation PCR assays from Hologics using the Procleix Panther® system. 1990-Dec 2010 LifeSouth Community Blood Centers, Inc. Gainesville, FL. Technical Director (full-time hours worked)  Provided technical and administrative direction to a staff of 24 team members working in a highly automated donor-testing laboratory performing approximately 3,000,000 tests per year.  Provided technical and administrative direction to highly qualified staff of seven specialists Page 1 of 4 Achieve Office (727) 578-3226 Cell (352) 275-4235 E-mail Gam0811@yahoo.com 108 44th AVE NE St. Pete, FL. 33703
  • 2. who worked in a reference and quality control laboratory performing highly specialized immunohematology, hematology, molecular and flowcytometry assays.  Developed LifeSouth’s training program for Medical Technologists in 2006. The program is licensed by the State of Florida, license number TP 258.  Developed LifeSouth’s bilingual translation services for blood donation  Hired and retained a core group of outstanding managers, supervisors, and technical staff.  Research coordinator and sub-investigator of a protocol determining the value of banking cord blood for transplantation (BB-IND 7520).  Research coordinator and sub-investigator of a protocol evaluating the use of TMA to detect WNV in volunteer blood donors (2003BBWBWNV- 04)  Research coordinator of a post-market study titled “Identification of Confirmed HBV Yield Cases Using the PROCLEIX ULTRIO Assay in Blood Donations”  Research coordinator and sub-investigator of protocols evaluating the use RT-PCR to detect HIV (Protocol No: AS-HIV-046), and HCV in volunteer blood donors (Protocol No: AS- HCV-025)  Deputy Project Director for HRSA’s contract with LifeCord in support of the National Cord Blood Inventory HHSH234200867003C Medical Technologist (full-time hours worked)  1986–1989 Veterans Administration Medical Center. Gainesville, FL  General clinical lab duties Medical Technologist (part-time 20 hours per pay period)  1987–1988 Shands Teaching Hospital. Gainesville, FL  Part-time Blood Bank 1983–1986 Alachua General Hospital. Gainesville, FL (full-time hours worked)  General clinical lab duties 1978–1982 US Navy  Hospital Corpsman Education 1990–1994 University of Central Florida. Orlando, FL  MS, Health Services Administration 1982–1986 University of Florida. Gainesville FL  BS, Medical Technology Page 2 of 2
  • 3. 2016 - Villanova University on line • Lean Six Sigma certificate. • Pursuing Six Sigma Black Belt certification with emphasis in health care Skills  Speak Spanish fluently.  Experienced user of MS Office software.  Knowledgeable of FDA, CMS, and OHRP regulations, as well as good laboratory practices, CAP and AABB Standards.  Yellow belt in Six Sigma.  Lean practitioner certificate from Villanova University Affiliations American Society for Quality American College of Health Care Executives American Legion American Society of Clinical Pathologists American Association of Blood Bank Publicatio ns  Abdel-Mageed A, del Rosario MLU, Hutcheson CE, Iturraspe JA, Martinez G, Roberts CG, Wingard JR: Effect of temperature variation and duration from collection to processing of umbilical HPC, cord blood units on cell number, viability, and clonogenic potential. Blood 90(10, Suppl 1):321b, Abstract #4194, 1997  Abdel-Mageed A, Hutcheson CE, Braylan RC, Metz SJ, Iturraspe JA, del Rosario MLU, Pardo PJ, Eckert N, Martinez G, Fisk DD, Sugrue MW, Roberts CF, Wingard JR: Feasibility of umbilical HPC, cord blood unit collection and processing for volume reduction and thawing: Effect on cell loss, viability, and clonogenic potential. Blood 90(10, Suppl 1):321b, Abstract #4195.Hubl, W. et. Al. Effect of Storage on Stem Cell Concentration and Viability in Cord Blood. ASH Abstract Submission.  Hubl W, Iturraspe J, Martinez GA, Hutcheson CE, Roberts CG, Fisk DD, Sugrue MW, Wingard JR, Braylan RC. Measurement of absolute concentration and viability of CD34+ cells in HPC, cord blood and HPC, cord blood products using fluorescent beads and cyanine Page 3 of 2
  • 4. nucleic acid dyes. Cytometry 1998; 34(3):121-127.  B. Martinez, et. Al. Comparative testing for weak expression of D antigen: manual tube testing vs. a semi-automated IgG gel system  G. Martinez, N. Haubert, G. Leparc, P. Williamson, R. Spizman, . Robertson G, S. Caglioti, J. Dunn-Williams, M. Dixon, Comparison of Reactive Rates Between EIA and Chemi- luminescent Donor Screening Assays. CONTROL ID: 2006291, AABB abstract 2013.  Evaluation of High Triglycerides Concentrations for Interference with Immucor’s DonorScreen-HLA® Assay. Guillermo Martinez1, Phillip C. Williamson, German F. Leparc, Jennifer Ritter, Sally Caglioti, Cheryl Amaral Page 4 of 2